StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.20−0.15 (-42.59%)

Close on Nov 13, 2026Market cap $906.90KP/E –Yield –

Oragenics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Oragenics's price to book ratio was 0.4× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 196.5×, with a median of 42.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×+0.1
2025Dec 31, 20250.3×−33.5
2024Dec 31, 202433.8×−33.0
2023Dec 29, 202366.8×+40.5
2022Dec 30, 202226.2×−30.2
2021Dec 31, 202156.4×−31.7
2020Dec 31, 202088.2×+52.2
2019Dec 31, 201936.0×+0.8
2018Dec 31, 201835.1×−319.4
2017Dec 29, 2017354.6×+171.1
2016Dec 30, 2016183.4×−301.8
2015Oct 30, 2015485.3×+398.9
2014Dec 31, 201486.4×−307.2
2013Oct 31, 2013393.6×+187.8
2012Dec 31, 2012205.8×–

More Oragenics figures

See a number that looks wrong?